Godefridus Johannes Peters#
| Membership Number: | 6688 |
| Membership type: | ORDINARY |
| Section: | CLINICAL & VETERINARY SCIENCE |
| Affiliated section(s): | BIOCHEMISTRY & MOLECULAR BIOLOGY |
| Elected: | 2023 |
| Main Country of Residence: | THE NETHERLANDS |
| Homepage(s): | http:// |
| ORCID: | 0000-0002-5447-2877 |
| Linkedin: | https://www.linkedin.com/in/godefridus-j-frits-peters-6aa9881a/ |
Present and Previous Positions
- 10/2019 - present Department of Biochemistry, Medical University of Gdansk, Poland
- 04/1983 - present Laboratory Medical Oncology, VU University Medical Center (VUMC) Amsterdam, the Netherlands, now part of the AUMC (Professor since 2003)
- 09/2015 until 09/2021 Teacher at the Amsterdam University College
- until 04/2018 Department head of the Laboratory Medical Oncology
- 01/1989 until 04/2018 Head of the division (Biochemical) Pharmacology
- 09/2002 until 01/2013 Chair of the examination committee of the Master Oncology
- 07/1982 until 04/1983 Post-doc at the Department of Biochemistry Netherlands Cancer Institute, Amsterdam, the Netherlands
- 09/1982 until 11/1982 Visiting scientist in Canada (Calgary, Edmonton) and USA (San Diego)
- 09/1977 until 06/1982 Ph.D. student at the Department of Biochemistry, University of Nijmegen (now Radboud University)
Fields of Scholarship
- Resistance to classical chemotherapeutics
- Genetic polymorphisms as markers for resistance, to select driver genes and provide personalized therapy of patients
- DNA repair
- Resistance to anti-signalling drugs
- Translation of preclinical pharmacology of anticancer agents to the clinic to achieve personalized therapy
- Epigenetics (methylation, acetylationb, miRNA) as marker and targets for cancer therapy
- Development of antimetabolites, including antifolates
- Drug development and drug discovery in general
- Pharmacogenetics of anticancer drugs (both conventional chemotherapy and "targeted" drugs
- Drug transport
- Cancer metabolism
Honours and Awards
- 1986 Senior research fellowship of the "Royal Netherlands Academy of Arts and Sciences" (KNAW).
- 2007 Eminent Scientist of the year 2007 (Europe) in “Genes and Pharmacogenomics”; awarded by the World Scientists Forum International Awards from the International Research Promotion Council (IRPC).
- 2008 Featured on the front page of International Journal of Oncology (January 2008)
- Featured in several Who is Who editions
- Recipient (or co-recipient) of various poster and best presentation awards.
- 2001 - 2003 President of the European Society for the Study on Purine and Pyrimidine metabolism in Man (ESSPPMM)
- 2007 co-founder of the successor of ESSPPMM, the Purine and Pyrimidine Society (2007)
- 2007 - 2017 chair Drug Discovery Committee (DDC) of the EORTC
- 2009 - 2015 President of the EORTC-Pharmacology and Molecular Mechanism Group; member of the board of the EORTC (European Organization on Research and Treatment of Cancer)
- 2010 - 2015 co-recipient of European Union grant for outermost regions in collaboration with the University of La Laguna (CIBICAN)
- 2014 co-president of the Folate Receptor Society meeting in the Netherlands
- 2014 treasurer of the Folate Receptor Society
- 2019 Burger-Kelland award lecture of the EORTC-PAMM group, Verona, Italy, February 2019.
- 2020 Full member of the World Academy of Sciences)
- 2021 Vice-president of the International Association of Physical Chemists
- 2021 Honorary Advisor of the Universal Scientific Education and Research Network (USERN)
- 2023 Honorary Professor at the Amity University, Noida, India
- 2023 Anne Simmonds Award lecture at the meeting of the Purine and Pyrimidine Society
- 2023 ranked #9 of Polish Scientists in the field of Medicine according to Research.com
- 2023 President of the 18th Annual Congress of International Drug Discovery Science & Technology
